Formyl Peptide Receptors
Products Related to Formyl Peptide Receptors(11)
- GC15319Cyclosporin HCAS: 83602-39-5Purity: >99.00%
Cyclosporin H is a potent and selective formyl peptide receptor (FPR) antagonist with an IC 50 value of 0.7μM.
- GC16673N-Formyl-Met-Leu-PheCAS: 59880-97-6Purity: >99.50%
N-Formyl-Met-Leu-Phe (fMLP) is an endogenous chemotactic peptide and an agonist of formyl peptide receptor 1 (FPR1) with a K i value of 38 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10691 | WRW4 | 878557-55-2 | >99.50% | |
WRW4 is a selective antagonist of formyl peptide receptor 2 (FPR2, formerly known as FPRL1), which is a synthetic C-terminal amidated hexapeptide, its IC 50 value for inhibiting the binding of WKYMVm to FPRL2 is 0.23 μM. | ||||
| GC11278 | Boc-MLF | 67247-12-5 | >98% | |
Boc-MLF is a tripeptide compound with FPR1 antagonistic activity. | ||||
| GC14275 | MMK 1 | 271246-66-3 | >98% | |
human formyl peptide receptor FPR2 agonist | ||||
| GC15319 | Cyclosporin H | 83602-39-5 | >99.00% | |
Cyclosporin H is a potent and selective formyl peptide receptor (FPR) antagonist with an IC 50 value of 0.7μM. | ||||
| GC15522 | Ac9-25 | 284040-76-2 | >98.50% | |
formyl peptide receptor 1 (FPR1) ligand | ||||
| GC16498 | WKYMVm | 187986-17-0 | >99.50% | |
WKYMVm, a synthetic peptide, is a potent Formyl peptide receptor 2 (FPR2) agonist, exerts an immunoregulatory effect. | ||||
| GC16673 | N-Formyl-Met-Leu-Phe | 59880-97-6 | >99.50% | |
N-Formyl-Met-Leu-Phe (fMLP) is an endogenous chemotactic peptide and an agonist of formyl peptide receptor 1 (FPR1) with a K i value of 38 nM. | ||||
| GC17016 | WKYMVM | 187986-11-4 | - | |
Selective agonist for the formyl peptide receptors FPR2 and FPR3 | ||||
| GC17409 | PBP 10 | 794466-43-6 | >98% | |
PBP 10 is a cell-permeable formyl peptide receptor 2 (FPR2) antagonist. | ||||
| GC17872 | FPR A14 | 329691-12-5 | >98% | |
Formyl peptide receptor (FPR) agonist | ||||
| GC50212 | Quin C1 | 786706-21-6 | >98% | |
Potent and selective FPR2 agonist | ||||
